Quest Diagnostics Inc. and Pathai Inc. established a forward-looking deal with multiple components and room for growth. The ...

Novartis AG is bolstering its radioligand arsenal with the takeout of Mariana Oncology Inc. for $1 billion up front and as ...

Epitel Inc. received U.S. FDA clearances for two epilepsy-focused technologies that simplify detection and analysis of ...

Despite a couple of med-tech deals transacted this year and more liquidity in the market, early-stage medical device ...

Novartis Pharma AG continues to build up its radiopharmaceutical powerhouse and has expanded a peptide discovery ...

Just a few days after the U.S. Congressional Research Service issued a report suggesting ways Congress could resolve the unanswered questions about patent listings in the FDA’s Orange Book, the FTC ...

While Nrx Pharmaceuticals Inc.’s oral antidepressant NRX-101 failed, producing a not statistically significant 33% reduction in suicidality along with a 70% reduction in the symptoms of akathisia, the ...

The U.S. FDA issued a handful of warning letters to device makers in the month of April 2024, one of which is for the Waukegan, Il., plant operated by Cardinal Health Inc., of Dublin, Ohio. While the ...

As Poseida Therapeutics Inc. anticipates reporting further data this year from allogeneic CAR T-cell therapy P-MUC1C-ALLO1, for which Astellas Pharma Inc. has nabbed first negotiation rights, the two ...

In what represents its first patenting, PBSF Inc. filed for protection of brain monitoring and neuroprotection strategies for ...

Newron Pharmaceuticals SpA added heft to the data supporting evenamide, reporting positive top-line results from a phase ...

Royal Philips NV has come to terms over class-action litigation in which plaintiffs alleged that particulate matter in ...